The board of directors of China Investment Fund Company Limited announced that a Risk Management Committee and an Investor Relations Committee have been formed with effect from 22 April 2016. The Board announced that Mr. Luo Ji has resigned as an independent non-executive Director of the company, a member of each of the Audit Committee, the Remuneration Committee, the Nomination Committee and the Special Investigation Committee in order to devote more time to his other business commitments. The company also announced appointment of Mr. Wang Mengtao (Mr. Wang) as a non-executive Director of the company, a vice-president of the Group and a member of the Investor Relations Committee; the appointment of Mr. Leung Ka Fai (Mr. Leung) as an independent non-executive Director of the company, a member of the Audit Committee and the chairman of each of the Remuneration Committee, the Nomination Committee, the Risk Management Committee and the Investor Relations Committee; the appointment of Mr. Luk Hong Man Hammond (Mr. Luk), executive Director of the company, as the chief executive officer of the Group and as a member of the Risk Management Committee; the appointment of Mr. Zhang Xi (Mr. Zhang), executive Director of the company, as chief investment officer of the Group and a member of the Remuneration Committee; the appointment of Mr. Leung Po Hon (Mr. Vincent Leung), independent non-executive Director of the Company, as a member of the Investor Relations Committee; the appointment of Mr. Wong Chung Kin Quentin (Mr. Wong), independent non-executive Director of the Company, as a member of the Nomination Committee.

Mr. Wong will cease to be the chairman of the Remuneration Committee; and Mr. Vincent Leung will cease to be a member of the Nomination Committee. Following the suspension of Ms. Li Jiangtao's (Ms. Li) duties as set out in the announcement of the company dated 19 January 2016, the Board also announced that Ms. Li has been removed as a member of the Audit Committee, a member of the Remuneration Committee and the chairman of the Nomination Committee. Mr. Wang is currently an assistant director of the Center of Taoism Business School and a general manager of Shenzhen Zhi Chong Culture Broadcast Co.

Ltd. and Mr. Leung Ka Fai (Mr. Leung) has been an independent non-executive Director of Rui Kang Pharmaceutical Group Investments Limited.